#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vaginal cancer Henoch-Schonlein purpura Leiomyosarcoma Facioscapulohumeral muscular dystrophy Arginase deficiency Richter's syndrome Metastatic gastric cancer Asthma Ewing's sarcoma metastatic Acute lymphocytic leukaemia Neurofibromatosis Langerhans' cell histiocytosis Adenocarcinoma pancreas Neurodegenerative disorder ROHHAD syndrome More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Diagnostics Idiopathic pulmonary fibrosis Factor IX deficiency – Life with Disease Haemophilia B without inhibitors – Trials in Disease Breast angiosarcoma – Diagnostics Antisynthetase syndrome – Trials in Disease Hereditary ataxia Breast angiosarcoma metastatic – Treatment Stevens-Johnson syndrome – Treatment Netherton’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nandrolone Decanoate Linperlisib Patiromer TALADEGIB Indocyanine Green Gns561 Paroxetine TRIACYLGLYCEROL LIPASE Acalabrutinib Kbp-336 Coffee Charcoal NORELGESTROMIN GSKVX000000034798 Azelastine Sodium Nitrite Dexketoprofen Specific Nucleic Acid Sna-Papi Letermovir Topotecan Oxaliplatin More therapies…

    Learn about Your Condition

    Colonoscopy Caesarean section Retinopathy of prematurity Complex regional pain syndrome Hereditary ataxia Onychomycosis Chronic myeloid leukaemia Dermatitis Oedema Inclusion body myositis Epstein-Barr virus infection Developmental hip dysplasia Polymyalgia rheumatica Neurofibromatosis Trigeminal neuralgia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fakultni Nemocnice Plzen

Fakultni Nemocnice Plzen

Edvarda Benese 1128/13, Jizni Predmesti, Plzen, 301 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on Vitamin D3 (Colecalciferol) Supplementation in Young Adults and Seniors to Compare Effects and Develop Age-Specific Models

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    Czechia

  • Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tezepelumab
    Czechia Denmark Germany Italy Poland Slovakia +1

  • Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    • Pirtobrutinib
    • Venetoclax
    Austria Belgium Czechia Denmark Finland France +8

  • Study on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Amsacrine
    • Gilteritinib
    • Idarubicin Hydrochloride
    Czechia Germany Italy Lithuania Portugal Romania +1

  • Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Berotralstat
    Czechia France Germany Italy Poland Slovakia +1

  • Study on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Obicetrapib
    • Ezetimibe
    Czechia Hungary Italy The Netherlands Poland Spain

  • Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

    Recruiting

    3 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Furosemide Ph. Eur.
    Czechia Denmark Lithuania The Netherlands Sweden

  • Study of Catheter-Directed Thrombolysis Using Alteplase for Treatment of Intermediate-High Risk Acute Pulmonary Embolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Alteplase
    Czechia

  • Study on the Effects of Sodium Lactate and Saline Solutions in Patients with Septic Shock

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Sodium Lactate
    Czechia
Previous Page
1 2 3 4 … 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!